GRITSTONE BIO INC (GRTS)

US39868T1051 - Common Stock

0.8117  0 (-0.21%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
16.34M19.95M48.21M4.04M4.37M
Operating Expenses
155.97M140.37M123.42M110.05M102.31M
Research and Development
127.18M111.40M97.49M88.64M82.90M
Selling, General, and Administrative Expenses
28.78M28.97M25.93M21.41M19.41M
Operating Income
-139.62M-120.43M-75.21M-106.02M-97.94M
Interest Income/Expense
1.16M740.00K130.00K700.00K3.51M
Other Income/Expense
-32.00KN/AN/AN/AN/A
Income Before Taxes
-138.49M-119.69M-75.08M-105.31M-94.43M
Net Income
-138.49M-119.69M-75.08M-105.31M-94.43M
EBITDA
-132.03M-113.87M-68.86M-99.38M-93.19M
 
Per Share Data
EPS Diluted Total Ops
-1.52-1.32-0.95-2.79-2.81
Non GAAP EPS
-1.20-1.33-0.96-2.78-2.79
 
Statistics
Profit Margin
-847.34%-599.95%-155.74%-2606.68%-2160.87%
Operating Profit Margin
-854.26%-603.66%-156.00%-2624.26%-2241.19%

All data in USD

Charts